Market Research Logo

Indonesia Pharmaceuticals and Healthcare Report Q3 2015


Attention: There is an updated edition available for this report.

BMI Industry View
SWOT
Political
Economic
Operational Risk
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Indonesia 2011-2019)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Indonesia 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Indonesia 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Indonesia 2011-2019)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Indonesia 2011-2019)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Indonesia 2011-2019)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Indonesia 2011-2019)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Indonesia 2011-2019)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Indonesia 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts local currency (Indonesia 2013-2019)
Key Risks To BMI's Forecast Scenario
Macroeconomic Forecasts
Macroeconomic Forecast
Industry Risk Reward Indices
Asia Pacific Risk/Reward Index
Indonesia Risk/Reward Index
Rewards
Risks
Market Overview
Industry Trends And Developments
Epidemiology
Table: Estimated Number Of New Cases Of Cancer In Indonesia
Public Health Developments
Table: UN Millennium Development Goals For Indonesia
Healthcare System
Health Insurance
Health Insurance Developments
Healthcare System Reform
Table: Healthcare Resources (Indonesia 2009-2014)
Table: Healthcare Personnel (Indonesia 2009-2014)
Table: Healthcare Activity (Indonesia 2009-2014)
Medical Tourism
Research & Development
Clinical Trials
Herbal Medicines
Regulatory Development
Pharmaceutical Advertising
Regional Harmonisation
Intellectual Property Issues
Halal Medicine Regulations
Labelling Requirements
Compulsory Licensing
Counterfeit Drugs
Generic Drug Legislation
Free Trade Agreements
Pricing Regime
Reimbursement Regime
Competitive Landscape
Research-Based Industry
Table: Selected List Of Pharmaceutical Business Areas With Restricted Conditions
Table: Top-10 Pharmaceutical Companies According To Market Capitalisation
Generic Drugmakers
Recent Pharmaceutical Industry Developments
Pharmaceutical Wholesale
Pharmaceutical Retail
Company Profile
Soho Group
Darya-Varia Group
PT Kalbe Farma
PT Biofarma
Kimia Farma
Combiphar PT
Indopharma
Sanofi
Pfizer
Novartis
GlaxoSmithKline
Merck & Co
Bayer
Merck Group
Demographic Forecast
Demographic Outlook
Table: Population Headline Indicators (Indonesia 1990-2025)
Table: Key Population Ratios (Indonesia 1990-2025)
Table: Urban/Rural Population And Life Expectancy (Indonesia 1990-2025)
Table: Population By Age Group (Indonesia 1990-2025)
Table: Population By Age Group % (Indonesia 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Indonesia Pharmaceuticals and Healthcare Report Q3 2015

BMI View: Indonesia's healthcare expenditure will grow robustly. Key to this trajectory is rising householdincomes which will have strong positive ramifications due to the dominant role of private spending as asource of healthcare financing. This will be further augmented by the roll out of universal healthcare whichwill improve access to medical services and in turn create commercial opportunities that will drive theexpansion of private hospitals - a boon to Indonesia's healthcare infrastructure.

Headline Expenditure Projections

Pharmaceuticals: IDR70,402bn (USD5.9bn) in 2014 to IDR77,644bn(USD5.88bn) in 2015; +10.3%growth in local currency terms and -0.8% in US dollar terms. Forecast upgraded with the addition of newdata.

Healthcare: IDR311,131bn (USD26.22bn) in 2014 to IDR347,254bn (USD26.3bn) in 2015; +11.6%growth in local currency terms and 0.4% in US dollar terms. Forecast downgraded with the addition ofnew data.


Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report

;